Article

Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells.

Department of Physiology, Nijmegen Center for Molecular Life Sciences, Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands.
Molecular Biology of the Cell (Impact Factor: 4.55). 01/2005; 15(12):5693-9. DOI: 10.1091/mbc.E04-04-0337
Source: PubMed

ABSTRACT Binding of arginine-vasopressin (AVP) to its V2 receptor (V2R) in the basolateral membrane of principal cells induces Aquaporin-2-mediated water reabsorption in the kidney. To study the regulation of the V2R by dDAVP in a proper model, a polarized renal cell line stably-expressing V2R-GFP was generated. Labeled AVP-binding studies revealed an equal basolateral vs. apical membrane distribution for V2R-GFP and endogenous V2R. In these cells, GFP-V2R was expressed in its mature form and localized for 75% in the basolateral membrane and for 25% to late endosomes/lysosomes. dDAVP caused a dose- and time-dependent internalization of V2R-GFP, which was completed within 1 h with 100 nM dDAVP, was prevented by coincubation with a V2R antagonist, and which reduced its half-life from 11.5 to 2.8 h. Semiquantification of the V2R-GFP colocalization with E-cadherin (basolateral membrane), early endosomal antigen-1 (EEA-1) and lysosome-associated membrane protein-2 (LAMP-2) in time revealed that most dDAVP-bound V2R was internalized via early endosomes to late endosomes/lysosomes, where it was degraded. The dDAVP-internalized V2R did not recycle to the basolateral membrane. In conclusion, we established the itinerary of the V2R in a polarized cell model that likely resembles the in vivo V2R localization and regulation by AVP to a great extent.

0 Followers
 · 
147 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Body water balance is regulated via the water channel aquaporin-2 (AQP2), which is expressed in the renal connecting tubule (CNT) and collecting duct (CD). The relative roles of AQP2 in the CNT and CD are not fully understood. To study the role of AQP2 in the CNT we generated a mouse model with CNT-specific AQP2 deletion (AQP2-CNT-KO). Confocal laser scanning microscopy and immunogold electron microscopy demonstrated an absence of AQP2 in the CNT of AQP2-CNT-KO mice. 24 hour urine output was significantly increased (KO: 3.0±0.3; WT: 1.9±0.3 mL/20 g BW) and urine osmolality decreased (KO: 1179±107; WT: 1790±146 mOsm/kg) in AQP2-CNT-KO mice compared to controls. After 24 hour water restriction, urine osmolality was still significantly lower in AQP2-CNT-KO mice (KO: 2087±169; WT: 2678±144 mOsm/kg). A significant difference in urine osmolality between groups before dDAVP (KO: 873±129; WT: 1387±163 mOsm/kg) was not apparent 2 hours after injection, with urine osmolality increased significantly in both groups (KO: 2944±41; WT: 3133±66 mOsm/kg). Cortical kidney fractions from AQP2-CNT-KO mice had significantly reduced AQP2, with no compensatory changes in NKCC2, AQP3 or AQP4. Lithium chloride treatment increased urine volume and decreased osmolality in both wildtype and AQP2-CNT-KO mice. After 8 days treatment, the AQP2-CNT-KO mice still had a significantly higher urine volume and lower urine osmolality, suggesting that the CNT does not play a significant role in the pathology of lithium induced NDI. Our studies indicate that the CNT plays a role in regulating body water balance under basal conditions, but not for maximal concentration of the urine during antidiuresis.
    The Journal of Physiology 01/2013; DOI:10.1113/jphysiol.2012.250852 · 4.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aquaporin-2 (AQP2) water channels in principal cells of the kidney collecting duct are essential for urine concentration. Due to application of modern technologies, progress in our understanding of AQP2 has accelerated in recent years. In this article, we highlight some of the new insights into AQP2 function that have developed recently, with particular focus on the cell biological aspects of AQP2 regulation. AQP2 is subjected to a number of regulated modifications, including phosphorylation and ubiquitination, which are important for AQP2 function, cellular localization and degradation. AQP2 is likely internalized via clathrin and non-clathrin-mediated endocytosis. Regulation of AQP2 endocytosis, in addition to exocytosis, is a vital mechanism in determining overall AQP2 membrane abundance. AQP2 is associated with regulated membrane microdomains. Studies using membrane cholesterol depleting reagents, for example statins, have supported the role of membrane rafts in regulation of AQP2 trafficking. Noncanonical roles for AQP2, for example in epithelial cell migration, are emerging. AQP2 function and thus urine concentration is dependent on a variety of cell signalling mechanisms, posttranslational modification and interplay between AQP2 and its lipid environment. This complexity of regulation allows fine-tuning of AQP2 function and thus body water homeostasis.
    Current Opinion in Nephrology and Hypertension 07/2013; 22(5). DOI:10.1097/MNH.0b013e328364000d · 4.24 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Binding of vasopressin to its type-2 receptor in renal collecting ducts induces cAMP signaling, transcription and translocation of aquaporin-2 (AQP2) water channels to the plasma membrane and water reabsorption from the pro-urine. Demeclocycline is currently used to treat hyponatremia in patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Demeclocycline's mechanism of action, which is poorly understood, is studied here. In mouse cortical collecting duct (mpkCCD) cells, which exhibit dDAVP-dependent expression of endogenous AQP2, demeclocycline decreased AQP2 abundance and gene transcription, but not its protein stability. Demeclocycline did not affect V2R localization, but decreased dDAVP-induced cAMP generation and adenylate cyclase 3 and 5/6 abundances. Addition of exogenous cAMP partially corrected the demeclocycline effect. As in patients, demeclocycline increased urine volume, decreased urine osmolality and reverted hyponatremia in an SIADH rat model. AQP2 and adenylate cyclase 5/6 abundances were reduced in the inner medulla, but increased in the cortex and outer medulla, in the absence of any sign of toxicity. In conclusion, our in vitro and in vivo data indicate that demeclocycline mainly attenuates hyponatremia in SIADH by reducing adenylate cyclase 5/6 expression, and consequently cAMP generation, AQP2 gene transcription and AQP2 abundance in the renal inner medulla, coinciding with a reduced vasopressin-escape response in the other collecting duct segments.
    AJP Renal Physiology 10/2013; 305(12). DOI:10.1152/ajprenal.00723.2012 · 4.42 Impact Factor

Full-text (2 Sources)

Download
12 Downloads
Available from
Oct 1, 2014